Mucor is a saprophytic organism and commonly invades the nose and paranasal sinuses of immunocompromised and diabetic patients. Middle ear involvement is extremely uncommon. Early diagnosis based on strong clinical suspicion with radical debridement in the early setting under amphotericin cover offers a suitable management option.
Yun MW, Lui CC, Chen WJ. Am J Otol 1994;15(3):413–414
Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards JJ, Jr., Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clinical Infectious Diseases 2009;48(12):1743–1751.
Zilberberg MD, Shorr AF, Huang H, et al. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infectious Diseases 2014;14
Turunc T, Demiroglu YZ, Aliskan H, Colakoglu S, Arslan H. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Research and Clinical Practice 2008;82(2):203–208
Gussen R, Canalis RF. Mucormycosis of the temporal bone. Ann Otol Rhinol laryngol 1982;91:27–32
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases. 2012;54 (supplement 1).
Bergstrom L, Hemenway WG, Barnhant RA, et al. Rhinocerebral and otologic mucormycosis. Ann Otol Rhinol Laryngol 1970; 79:70–81.
Price JC, Stevans DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis.